This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Futuragene Israel Ltd.. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Dror Avisar: Innovator in Transgenic Plant Technology
Introduction
Dror Avisar is a prominent inventor based in Kochav Yair, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic plants. With a total of 4 patents to his name, Dror's work focuses on innovative solutions for agricultural challenges.
Latest Patents
Dror Avisar's latest patents include groundbreaking inventions such as "Bacterial resistant transgenic plants having dysfunctional T3SS proteins." This patent discloses a nucleic acid expression vector that comprises a nucleic acid sequence encoding a dominant negative T3SS protein. The vector also includes a cis-acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Furthermore, the dominant negative T3SS protein mediates the assembly of a dysfunctional needle complex.
Another notable patent is related to "Bronze bug control agents." This invention pertains to RNA-mediated gene silencing in insect species, specifically targeting the invasive Bronze bug pest. The patent is based on the sequencing of genes from this pest and provides Bronze bug nucleic acids, derivatives thereof, and their use as control agents.
Career Highlights
Dror Avisar is currently associated with Futuragene Israel Ltd., where he continues to advance his research and innovations in biotechnology. His work has garnered attention for its potential impact on sustainable agriculture and pest management.
Collaborations
Dror has collaborated with notable colleagues, including Hanan Stein and Ziv Shani, to further enhance the scope and application of his inventions.
Conclusion
Dror Avisar's contributions to the field of biotechnology exemplify the innovative spirit of modern inventors. His patents not only address pressing agricultural issues but also pave the way for future advancements in transgenic technology.